Therapy of common arrhythmias.
D000200:Action Potentials; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000633:toxicity; D001145:Arrhythmias, Cardiac / Q000145:classification / Q000150:complications / Q000628:therapy*; D001919:Bradycardia / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D005334:Fever / Q000150:complications; D006325:Heart Atria; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D007022:Hypotension / Q000150:complications / Q000188:drug therapy; D008173:Lung Diseases, Obstructive / Q000150:complications; D008729:Methoxamine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000150:complications; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000175:diagnosis; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014693:Ventricular Fibrillation
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D004077:Digoxin; D011433:Propranolol; D008729:Methoxamine; D011802:Quinidine; D011342:Procainamide